Lupin Limited, (BSE:500257 NSE:LUPIN), Corporate News, Latest News

Markets	Companies	Research	Industries	E-Mail Page

Wealth Tracker

my Last 5 Scrips
Company	BSE Price(Rs)	% Chg
Yes Bank	16.55
Tata Stl	106.75	2.15
Vedl	304.75	9.66
State Ba	610.80	7.20
Ntpc Ltd	175.80	4.24
Clear All	Clear Last

Equity

NSE Live
Nifty Live Prices Live Quotes Top Gainers/Losers Top 10 Turnover No Delivery Stocks

BSE Live
BSE30 Live Prices Live Quotes Top Gainers/Losers Top 10 Turnover No Delivery Stocks

Market Pulse
Leaders Laggards FII Activity Mutual Fund Activity Meetings

Results Watch
Results Calendar Results Announced

IPO Watch

Company
Snapshots Quotes Charts Financials Recent News Broker Research Meetings Research Tutorial Discussion Forum

Research
Research Reports

News Watch

Sector Watch

Economy Watch

News-Lupin Limited

Lupin Limited

Sector:Pharmaceuticals Pharmaceuticals - Bulk Drugs
BSE:500257	NSE:LUPIN	Bloomberg:[email protected]	Reuters:LUPN.BO
Market Lot: 1	Face Value: 2	ISIN Demat: INE326A01037

Quotes	Snapshot	Charts	Financials	Research	Recent News
Peer Group	AGM/AM	MF Holding	Discussion Forum	BSE/NSE Notices	BSE/NSE Deals

Corporate News
08-Mar-2022	Lupin signs Mary Kom as brand ambassador for Shakti initiative IRIS
09-Feb-2022	Lupin gets USFDA's nod for Arformoterol Tartrate Inhalation Solution IRIS
28-Jan-2022	Lupin signs promotional agreement with Exeltis IRIS
18-Jan-2022	Lupin gets nod to acquire portfolio of brands of Anglo-French Drugs & Industries IRIS
14-Dec-2021	Lupin's Goa manufacturing plant gets EIR from USFDA IRIS
06-Dec-2021	Lupin enters into pact with Biomm IRIS
29-Sep-2021	Lupin launches Droxidopa Capsules in United States IRIS
07-Sep-2021	Lupin and TB Alliance announce commercial partnership for new therapy IRIS
25-Aug-2021	Lupin arm launches Luforbec for asthma and COPD treatment in UK IRIS
16-Aug-2021	Lupin receives tentative USFDA nod for Brivaracetam Tablets IRIS
17-Jun-2021	Lupin receives USFDA nod for Sevelamer Hydrochloride Tablets IRIS
07-Jun-2021	Lupin launches Digital Asthma Educator platform IRIS
07-Jun-2021	Lupin receives USFDA nod for Emtricitabine and Tenofovir Disoproxil Fumarate Tablets IRIS
04-Jun-2021	Lupin launches authorized generic version of Brovana in United States IRIS
03-Jun-2021	Lupin to enter digital helthcare space in India IRIS
03-Jun-2021	Lupin announces USFDA acceptance for Pegfilgrastim Biosimilar application IRIS
27-May-2021	Lupin receives payment of USD 50 mn from Boehringer Ingelheim IRIS
10-May-2021	Lupin enters into licensing agreement with Lilly IRIS
23-Apr-2021	Lupin incorporates wholly owned subsidiary in USA IRIS
24-Mar-2021	LupinLife partners with Uttarakhand Police to promote Hand Hygiene at Kumbh Mela 2021 IRIS